CCL22 and myeloid sarcoma: Myelin basic protein, macrophage-derived chemokine and 5,6-dihydroxyprostaglandin were associated with worse disease progression in SP-MS patients, suggesting that they may be useful for monitoring disease course and treatment of SP-MS patients [28].